Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data
Nonalcoholic fatty liver disease (NAFLD) is the most common, chronic liver disease worldwide. Within this spectrum, steatosis alone is apparently benign, while nonalcoholic steatohepatitis may progress to cirrhosis and hepatocellular carcinoma. NAFLD is strongly associated with obesity, dyslipidemia...
Main Authors: | A. N. Mavrogiannaki, I. N. Migdalis |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2013/450639 |
Similar Items
-
Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency
by: I G Bakulin, et al.
Published: (2017-02-01) -
Nonalcoholic fatty liver disease and Type 2 diabetes mellitus
by: Mala Dharmalingam, et al.
Published: (2018-01-01) -
Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
by: Giandomenico Bisaccia, et al.
Published: (2020-06-01) -
Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese
by: Claudia B.M. Strey, et al.
Published: (2018-07-01) -
Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease
by: Arvind, A., et al.
Published: (2022)